Evaluating The Entire Package System Under USP 382

USP 382 represents a significant evolution in how pharmaceutical packaging systems are evaluated, moving beyond individual components to assess the performance of the entire system under real-world conditions. This holistic approach focuses on ensuring that elastomeric closures and delivery systems maintain integrity, sterility, and functionality throughout their lifecycle. A key element is container closure integrity testing (CCIT), which increasingly relies on deterministic methods such as vacuum decay and helium leak detection to provide more sensitive and reliable results. Additional functional tests evaluate factors such as penetration force, self-sealing capacity, and device usability, all tailored to the intended use and patient population. By emphasizing system-level performance and real-use simulation, USP 382 helps developers better understand interactions between drug products and packaging, ultimately reducing risk and supporting safer, more effective pharmaceutical delivery.